Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 4:19 a.m.

    📋 SAB BIOTHERAPEUTICS, INC. (SABS) - Clinical Trial Update

    Filing Date: 2022-06-06

    Accepted: 2022-06-06 13:35:51

    Event Type: Clinical Trial Update

    Event Details:

    SAB Biotherapeutics (SABS) Announces Clinical Trial Update SAB Biotherapeutics (SABS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: patients, programs
    • Diseases/Conditions: all phases of global clinical development, human donors
    • Collaboration: pre-IND

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: SAB Biotherapeutics
    • CIK: 0001833214
    • Ticker Symbol: SABS
    • Period End Date: 2022-06-06
    • Document Type: 8-K

Search

News categories